4.6 Article

In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity

Journal

PLOS ONE
Volume 8, Issue 6, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0064388

Keywords

-

Funding

  1. Australian National Health and Medical Research Council the Queensland Cancer Council
  2. National Breast Cancer Foundation
  3. Griffith University

Ask authors/readers for more resources

Mammosphere and breast tumoursphere culture have gained popularity as in vitro assays for propagating and analysing normal and cancer stem cells. Whether the spheres derived from different sources or parent cultures themselves are indeed single entities enriched in stem/progenitor cells compared to other culture formats has not been fully determined. We surveyed sphere-forming capacity across 26 breast cell lines, immunophenotyped spheres from six luminal- and basal-like lines by immunohistochemistry and flow cytometry and compared clonogenicity between sphere, adherent and matrigel culture formats using in vitro functional assays. Analyses revealed morphological and molecular intra- and inter-sphere heterogeneity, consistent with adherent parental cell line phenotypes. Flow cytometry showed sphere culture does not universally enrich for markers previously associated with stem cell phenotypes, although we found some cell-line specific changes between sphere and adherent formats. Sphere-forming efficiency was significantly lower than adherent or matrigel clonogenicity and constant over serial passage. Surprisingly, self-renewal capacity of sphere-derived cells was similar/lower than other culture formats. We observed significant correlation between long-term-proliferating-cell symmetric division rates in sphere and adherent cultures, suggesting functional overlap between the compartments sustaining them. Experiments with normal primary human mammary epithelia, including sorted luminal (MUC1(+)) and basal/myoepithelial (CD10(+)) cells revealed distinct luminal-like, basal-like and mesenchymal entities amongst primary mammospheres. Morphological and colony-forming-cell assay data suggested mammosphere culture may enrich for a luminal progenitor phenotype, or induce reversion/relaxation of the basal/mesenchymal in vitro selection occurring with adherent culture. Overall, cell line tumourspheres and primary mammospheres are not homogenous entities enriched for stem cells, suggesting a more cautious approach to interpreting data from these assays and careful consideration of its limitations. Sphere culture may represent an alternative 3-dimensional culture system which rather than universally 'enriching' for stem cells, has utility as one of a suite of functional assays that provide a read-out of progenitor activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content

Devika Ganesamoorthy, Alan James Robertson, Wenhan Chen, Michael B. Hall, Minh Duc Cao, Kaltin Ferguson, Sunil R. Lakhani, Katia Nones, Peter T. Simpson, Lachlan J. M. Coin

Summary: This study conducted deep sequencing analysis of plasma samples, revealing a higher fraction of unique somatic mutations in plasma samples that were not detected in matched tumour samples. Sequencing of di-nucleosome bound cfDNA fragments may increase recovery of tumour mutations from plasma.

BMC CANCER (2022)

Article Oncology

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases

Malcolm Lim, Tam H. Nguyen, Colleen Niland, Lynne E. Reid, Parmjit S. Jat, Jodi M. Saunus, Sunil R. Lakhani

Summary: This study investigated the relationship between brain metastases and drug treatment in HER2+ breast cancer patients. The results showed that brain metastases from breast, ovarian, lung, and kidney cancers have higher levels of HER2-HER3 dimers compared to other primary tumor types. However, traditional HER2-targeted therapies, such as pertuzumab, have limited inhibitory effects on HER2-HER3 dimerization in the presence of excess neuregulin, which may explain the occurrence of brain metastases.

CANCERS (2022)

Article Oncology

Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients

Kekoolani S. Visan, Richard J. Lobb, Shu Wen Wen, Justin Bedo, Luize G. Lima, Sophie Krumeich, Carlos Palma, Kaltin Ferguson, Ben Green, Colleen Niland, Nicole Cloonan, Peter T. Simpson, Amy E. McCart Reed, Sarah J. Everitt, Michael P. MacManus, Gunter Hartel, Carlos Salomon, Sunil R. Lakhani, David Fielding, Andreas Moeller

Summary: Lung cancer is a leading cause of cancer-related death worldwide and has low survival rates due to lack of early detection. A study on a lung cancer biomarker based on a simple blood test shows promising advantages for diagnostic assessment. The study identifies a specific micro-RNA, miR-3182, as a potential biomarker for lung cancer diagnosis that can be detected in the blood.

CANCERS (2022)

Review Cell Biology

Survey of recurrent diagnostic challenges in breast phyllodes tumours

Benjamin Yongcheng Tan, Stephen B. Fox, Sunil R. Lakhani, Puay Hoon Tan

Summary: Grading of breast phyllodes tumors (PTs) varies due to differences in weighting of grading criteria by pathologists. Key diagnostic criteria include increased stromal cellularity, stromal overgrowth, increased stromal mitoses, stromal atypia, stromal fronding, irregular tumor borders, and/or lesional heterogeneity. Clinical and radiological findings, as well as age, also play important roles in determining the diagnosis.

HISTOPATHOLOGY (2023)

Review Cell Biology

Hereditary breast cancer: syndromes, tumour pathology and molecular testing

A. Sokolova, K. J. Johnstone, A. E. McCart Reed, P. T. Simpson, S. R. Lakhani

Summary: Hereditary factors, including pathogenic variants in genes such as BRCA1, BRCA2, ATM, CHEK2, etc., play a significant role in breast cancer risk. Polygenic risk, which results from carrying multiple low-penetrance breast cancer susceptibility alleles, also contributes to the risk. This review provides an overview of established breast cancer susceptibility genes, breast cancer predisposition syndromes, and discusses the implications of molecular testing and therapy in hereditary breast cancer.

HISTOPATHOLOGY (2023)

Article Cell Biology

Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast

Nur Diyana Md Nasir, Valerie C. Y. Koh, Ian A. Cree, Blanca I. I. Ruiz, Javier Del Aguila, Subasri Armon, Stephen B. Fox, Sunil R. Lakhani, Puay Hoon Tan

Summary: In this study, an evidence gap map (EGM) was developed based on the literature cited in the PT chapter of the breast WCT. The EGM revealed a lack of high-level evidence citations and an uneven distribution of references. Future work is needed to bridge evidence gaps and broaden citations.

HISTOPATHOLOGY (2023)

Article Oncology

Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples

David I. Fielding, Andrew J. Dalley, Mahendra Singh, Lakshmy Nandakumar, Vanessa Lakis, Haarika Chittoory, David Fairbairn, Ann-Marie Patch, Stephen H. Kazakoff, Kaltin Ferguson, Farzad Bashirzadeh, Michael Bint, Carl Pahoff, Jung Hwa Son, Alan Hodgson, Sowmya Sharma, Nicola Waddell, Sunil R. Lakhani, Gunter Hartel, Katia Nones, Peter T. Simpson

Summary: Microscopy of Diff-Quik smears can predict DNA yield and be used for molecular diagnostics. This method can be a better alternative to traditional cell block testing.

CANCER CYTOPATHOLOGY (2023)

Article Cell Biology

BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme

Heather Thorne, Lisa Devereux, Jason Li, Kathryn Alsop, Liz Christie, Courtney T. van Geelen, Nikki Burdett, Kathleen Pishas, Noel Woodford, Jodie Leditschke, Mohamed H. M. A. Izzath, Kate Strachan, Gregory Young, Rufaro D. Jaravaza, Mohammed S. Madadin, Melanie Archer, Joanna Glengarry, Linda Iles, Ajith Rathnaweera, Clare Hampson, Khamis Almazrooei, Michael Burke, Pradeep Bandara, David Ranson, Essa Saeedi, Orla McNally, Linda Mileshkin, Anne Hamilton, Sumitra Ananda, George Au-Yeung, Yoland Antill, Shahneen Sandhu, Peter Savas, Prudence A. Francis, Stephen Luen, Sherene Loi, Ross Jennens, Clare Scott, Kate Moodie, Margaret Cummings, Andrew Reid, Amy McCart Reed, David Bowtell, Sunil R. Lakhani, Stephen Fox

Summary: This study aims to examine the metastatic patterns of breast, ovarian, and prostate cancer in germline BRCA1/2 mutation carriers and non-carriers through a rapid autopsy program. It found significant differences in the patterns of metastases in breast and ovarian cancer between BRCA1/2 carriers and non-carriers, while no significant differences were observed in prostate cancer. The findings have implications for clinical diagnostic imaging in monitoring metastases.

HISTOPATHOLOGY (2023)

Review Oncology

Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials

Isobel P. Taylor, J. Alejandro Lopez

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a common and difficult-to-treat cancer. Surgical resection and chemotherapy are the standard treatments, but the clinical outcomes are still poor. This paper reviews the clinical trials of conditionally-replicative adenoviruses in pancreatic cancer, providing a summary of the current literature and future prospects of this therapy.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Oncology

COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis

Janelle L. Hancock, Murugan Kalimutho, Jasmin Straube, Malcolm Lim, Irma Gresshoff, Jodi M. Saunus, Jason S. Lee, Sunil R. Lakhani, Kaylene J. Simpson, Ashley I. Bush, Robin L. Anderson, Kum Kum Khanna

Summary: This study found that loss of the COMMD3 gene promotes aggressive behavior in breast cancer cells and is associated with a lower survival rate. Further experiments showed that COMMD3 is involved in copper signaling and functions by regulating the expression of the Na+/K+-ATPase subunit ATP1B1.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Redefining normal breast cell populations using long noncoding RNAs

Maina Bitar, Isela Sarahi Rivera, Isabela Almeida, Wei Shi, Kaltin Ferguson, Jonathan Beesley, Sunil R. Lakhani, Stacey L. Edwards, Juliet D. French

Summary: Single-cell RNAseq has revealed the expression of thousands of long noncoding RNAs (lncRNAs) in human mammary epithelial cells, providing new insights into breast cell subpopulations. Clustering cells based on lncRNA expression can better discern basal subpopulations compared to annotated gene expression. Tissue-specific annotation of lncRNAs is necessary for accurate expression analysis. Breast-specific lncRNAs can serve as potential biomarkers and therapeutic targets for breast cancer subtypes.

NUCLEIC ACIDS RESEARCH (2023)

Article Oncology

Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure

Andrew Causer, Xiao Tan, Xuehan Lu, Philip Moseley, Siok M. Teoh, Natalie Molotkov, Margaret McGrath, Taehyun Kim, Peter T. Simpson, Christopher Perry, Ian H. Frazer, Benedict Panizza, Rahul Ladwa, Quan Nguyen, Jazmina L. Gonzalez-Cruz

Summary: In this study, advanced integrative spatial proteogenomic analysis was used to investigate the role of spatial determinants in cancer therapy outcomes. The researchers found that spatial transcriptomics successfully detected tumor cells and allowed for the investigation of phenotypic traits. Additionally, spatial proteomic imaging resolved the profiling of tumor infiltrating immune cells. The study also discovered clinically relevant alternative medicines based on their interaction with their matching ligand-receptor. Importantly, the researchers found that new tumors were not the product of immune checkpoint inhibitor (ICI) resistance but rather of a dose reduction due to complications.

NPJ PRECISION ONCOLOGY (2023)

No Data Available